In-stent thrombosis after 68 months of implantation inspite of continuous dual antiplatelet therapy: a case report

Lately, there has been an increased incidence of late stent thrombosis; especially following Drug eluting stent (DES) implantation. Several factors are associated with an increased risk of stent thrombosis, including the procedure itself, patient and lesion characteristics, stent design, and prematu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagrani, Tarun, Zaher, Medhat, Gaddam, Sainath, Jabbour, George, Baldari, Duccio, Baglini, Roberto, Duvvuri, Srinivas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844360/
https://www.ncbi.nlm.nih.gov/pubmed/20178570
http://dx.doi.org/10.1186/1757-1626-3-68
Descripción
Sumario:Lately, there has been an increased incidence of late stent thrombosis; especially following Drug eluting stent (DES) implantation. Several factors are associated with an increased risk of stent thrombosis, including the procedure itself, patient and lesion characteristics, stent design, and premature cessation of anti-platelet drugs. We present a case of late stent thrombosis (LST) following DES implantation after a period of 68 months, making it the longest reported case of LST reported in the literature, despite the use of dual anti-platelet therapy.

Ejemplares similares